Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 3Hot Flashes 2Depression 1

Interventions

Acupuncture Therapy 5Gabapentin 4Venlafaxine Hydrochloride 3Estrogens, Conjugated (USP) 3liposomal amphotericin B 2Tamoxifen 2Magnesium Oxide 2Hypnosis 2Control Groups 2Citalopram 2oxybutynin 1black cohosh root extract 1bazedoxifene 1Zolpidem 1Testosterone 1Tablets 1Soybean Proteins 1Solifenacin Succinate 1Sodium Chloride 1Sertraline 1Progesterone 1Pregabalin 1N,N'-(1,4-phenylenebis(methylene))dipyrimidin-2-amine 1Mindfulness 1Mind-Body Therapies 1Megestrol Acetate 1Medroxyprogesterone 1Linseed Oil 1Isoflavones 1Hypericum extract LI 160 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Hot Flashes × Citalopram × Breast × Clear all
NCT00667121 2025-02-14

Tamoxifen in Women With Breast Cancer and in Women at High-Risk of Breast Cancer Who Are Receiving Venlafaxine, Citalopram, Escitalopram, Gabapentin, or Sertraline

Mayo Clinic

Completed
88 enrolled
Breast

Breast Neoplasms, Depression, Hot Flashes

NCT00363909 2016-12-13

Citalopram in Treating Postmenopausal Women With Hot Flashes

Alliance for Clinical Trials in Oncology

Phase 3 Completed
254 enrolled
Breast

Breast Neoplasms, Hot Flashes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡